The wellness industry has found its newest frontier: measuring how old you really are at the cellular level. Biological age testing is being marketed as the next revolution in preventive health, a way to peek behind the curtain of chronological time and see your true biological destiny. Silicon Valley entrepreneurs are betting billions on it. Direct-to-consumer companies are packaging it as accessible, empowering, even necessary for anyone serious about their health.
This trend is being sold as inevitable. It deserves more skepticism than it is getting.
Don't misunderstand the position here. The underlying science exploring cellular aging is genuinely important. Understanding the mechanisms of aging could unlock real advances in disease prevention and longevity. But there is a canyon-sized gap between "this science is worth studying" and "you should pay a company to mail in a sample and get a score that predicts your health trajectory."
The problem starts with what these tests actually measure and, more importantly, what they claim to measure. Biological age markers like epigenetic clocks or telomere length might correlate with certain aging processes. That's different from being a reliable personal health forecast. A test result is not destiny. Yet the marketing language consistently walks right up to that line, implying that your biological age score tells you something definitive about your future.
Recent scientific findings should give us pause. When researchers have dug into high-profile health claims in related spaces, they have found surprising problems. Landmark studies have occasionally crumbled under closer scrutiny. Findings that seemed ironclad turned out to rest on statistical artifacts or methodological issues. That's how science works, but it also means caution is warranted when an industry is racing to commercialize results that are still being refined.
There is another concern: the psychological weight of these scores. Health behavior change is complex. Telling someone their biological age is five years higher than their chronological age might motivate them to exercise more. It might also trigger anxiety, spark unnecessary medical appointments, or fuel unhelpful obsession with metrics that may not actually reflect their health status. The informed consent conversation around psychological impact feels underdeveloped.
The business model itself raises questions. Companies profit from repeat testing. They profit from selling you interventions to lower your score. There is nothing inherently wrong with that, but it creates incentives that don't always align with scientific rigor or your actual health needs. It incentivizes marketing over restraint.
We should also consider what these tests displace. If someone invests time, money, and emotional energy into tracking a biological age score, they have fewer resources for things actually proven to extend healthspan: consistent movement, sleep quality, stress management, meaningful relationships, access to preventive care. These won't make a sleek direct-to-consumer product, but they have evidence behind them.
The reasonable take is not that biological age research should stop. It is that the gap between what we know and what we are selling deserves to be bigger than it currently is. Independent validation should come before mass marketing. The limitations of these tests should be stated as loudly as the possibilities.
We have a pattern in health and wellness: promising science gets commercialized faster than it gets proven, marketed to consumers before the evidence base is solid, and bundled with lifestyle products that may or may not help. Biological age testing is following that script almost exactly.
Skepticism is not anti-science. Sometimes it is the most scientific position available.